Patents Assigned to HORPHAG RESEARCH IP
  • PROCYANIDINS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION TRIGGERED BY COVID-19
    Publication number: 20230233634
    Abstract: A natural composition for medical purposes, more specifically including procyanidins, for use in the prevention or treatment of endothelial inflammation and/or endothelial systemic dysfunction triggered by Corona virus disease 2019 (COVID-19) including symptomatic post-COVID-19 subjects recovering from COVID-19.
    Type: Application
    Filed: June 9, 2021
    Publication date: July 27, 2023
    Applicant: HORPHAG RESEARCH IP (PYC) LTD.
    Inventors: Victor FERRARI, Carolina BURKI, Franziska WEICHMANN
  • PROCYANIDINS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION TRIGGERED BY COVID-19
    Publication number: 20210393580
    Abstract: A composition that includes procyanidins for use in the prevention or treatment of endothelial inflammation and/or endothelial systemic dysfunction triggered by Corona virus disease 2019 (COVID-19) including for use in treating symptomatic post-COVID-19 subjects recovering from COVID-19.
    Type: Application
    Filed: June 15, 2021
    Publication date: December 23, 2021
    Applicant: HORPHAG RESEARCH IP (PYC) LTD
    Inventors: Victor FERRARI, Carolina BURKI, Franziska WEICHMANN
  • Combination of proanthocyanidins and centella asiatica for the treatment of atherosclerosis
    Patent number: 9308230
    Abstract: The invention relates to a preparation for medical purposes and more specifically to a preparation consisting of the combination of proanthocyanidins such as Pycnogenol or grape seeds and Centella asiatica and/or extracts thereof, for use in the prevention or treatment of atherosclerosis.
    Type: Grant
    Filed: August 11, 2010
    Date of Patent: April 12, 2016
    Assignee: HORPHAG RESEARCH IP
    Inventors: Gianni Belcaro, Carolina Burki, Victor Ferrari
  • Abnormal intraocular pressure treatment
    Patent number: 9125925
    Abstract: Methods and compositions for reducing intraocular pressure in a patient, particularly a human patient, are described. In particular, compositions are disclosed that contain an anthocyanoside or an extract comprising it, a proanthhocyanidin or an extract comprising it and combinations thereof. The compositions are useful for lowering intraocular pressure.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: September 8, 2015
    Assignees: Horphag Research IP (MIR) Ltd., Indena S.P.A.
    Inventors: Victor Ferrari, Salvatore Malandrino, Carolina Burki, Frank Schoenlau
  • Ellagitannins rich extracts composition in sexual wellness
    Patent number: 9066924
    Abstract: The present invention relates to a composition consisting of ellagitannins rich extracts originated from plant extracts of the Fagaceae family, for use in a method for improving sexual fitness or wellness of both sexes, the male sexual enhancement, the treatment of sexual dysfunction and the health of the sexual vascular system of both sexes.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: June 30, 2015
    Assignee: HORPHAG RESEARCH IP (QR) LTD
    Inventors: Victor Ferrari, Frank Schoenlau, Carolina Burki
  • Ellagitannins rich extracts composition
    Patent number: 9060999
    Abstract: The present invention relates to a composition consisting of ellagitannins rich extracts originated from plant extracts of the Fagaceae family, for use in a method for preventing or treating sleep and anxiety disorders, fatigue as well as for improving mood, reducing tension and raising energy in a subject.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: June 23, 2015
    Assignee: HORPHAG RESEARCH IP (QR) LTD
    Inventors: Victor Ferrari, Frank Schoenlau, Carolina Burki
  • Composition for improving sexual wellness
    Patent number: 9028890
    Abstract: The invention relates to improving sexual fitness or wellness of both sexes, the male sexual enhancement, the treatment of sexual dysfunction and the health of the sexual vascular system of both sexes with ingredients that consist in a source of proanthocyanidins, a source of arginine, rose hip extracts and/or Quercus robur extracts. The source of proanthocyanidins may be a botanical extract and the source of arginine may be from arginine aspartate.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: May 12, 2015
    Assignee: Horphag Research (IP) Pre Ltd.
    Inventors: Victor Ferrari, Frank Schönlau, Carolina Burki
  • COMPOSITION FOR IMPROVING SEXUAL WELLNESS
    Publication number: 20130164394
    Abstract: The invention relates to improving sexual fitness or wellness of both sexes, the male sexual enhancement, the treatment of sexual dysfunction and the health of the sexual vascular system of both sexes with ingredients that consist in a source of proanthocyanidins, a source of arginine, rose hip extracts and/or Quercus robur extracts. The source of proanthocyanidins may be a botanical extract and the source of arginine may be from arginine aspartate.
    Type: Application
    Filed: June 24, 2011
    Publication date: June 27, 2013
    Applicant: HORPHAG RESEARCH (IP) PRE LTD.
    Inventors: Victor Ferrari, Frank Schönlau, Carolina Burki
  • COMBINATION OF PROANTHOCYANIDINS AND CENTELLA ASIATICA FOR THE TREATMENT OF ATHEROSCLEROSIS
    Publication number: 20120164244
    Abstract: The invention relates to a preparation for medical purposes and more specifically to a preparation consisting of the combination of proanthocyanidins such as Pycnogenol or grape seeds and Centella asiatica and/or extracts thereof, for use in the prevention or treatment of atherosclerosis.
    Type: Application
    Filed: August 11, 2010
    Publication date: June 28, 2012
    Applicant: HORPHAG RESEARCH IP (PYC) LTD.
    Inventors: Gianni Belcaro, Carolina Burki, Victor Ferrari